Group One Trading
CERE

Group One Trading’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Group One Trading’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,400
Closed -$384K – 7600
2024
Q2 		$384K Sell
9,400
-1,200
-11% -$50K ﹤0.01% 2813
2024
Q1 		$448K Sell
10,600
-31,300
-75% -$1.31M ﹤0.01% 2846
2023
Q4 		$1.78M Buy
41,900
+29,400
+235% +$845K ﹤0.01% 1973
2023
Q3 		$273K Sell
12,500
-6,400
-34% -$160K ﹤0.01% 3528
2023
Q2 		$601K Buy
18,900
+1,100
+6% +$33.8K ﹤0.01% 2838
2023
Q1 		$434K Sell
17,800
-24,900
-58% -$731K ﹤0.01% 2911
2022
Q4 		$1.35M Buy
42,700
+37,800
+771% +$1.07M ﹤0.01% 2164
2022
Q3 		$138K Sell
4,900
-22,100
-82% -$658K ﹤0.01% 4482
2022
Q2 		$714K Buy
27,000
+25,600
+1,829% +$727K ﹤0.01% 3088
2022
Q1 		$49K Sell
1,400
-20,300
-94% -$593K ﹤0.01% 6111
2021
Q4 		$704K Buy
21,700
+7,300
+51% +$258K ﹤0.01% 3727
2021
Q3 		$425K Buy
+14,400
New +$404K ﹤0.01% 4381

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Group One Trading's CERE Position: Q3 2024 in Review

Group One Trading sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 23,041 shares — an estimated $942K sold.

Group One Trading first reported a position in CERE in Q2 2022 and held it in 4 quarters. The position peaked at $1.14M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Group One Trading reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Group One Trading sold 23,041 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $942K.
  • Group One Trading first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Group One Trading's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.14M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.